16.75 USD
-1.3 (-7.2%)
ChartMill assigns a Buy % Consensus number of 84% to PRTC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 67.76. This target is 304.56% above the current price.
PRTC was analyzed by 5 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about PRTC.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed PRTC. So this is just the average opinion of a couple of analysts.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-08-25 | Piper Sandler | Maintains | Overweight |
| 2022-08-09 | SVB Leerink | Maintains | Outperform |
| 2022-06-15 | SVB Leerink | Maintains | Outperform |
| 2022-01-07 | SVB Leerink | Maintains | Outperform |
| 2021-08-25 | SVB Leerink | Maintains | Outperform |
| 2021-05-27 | Peel Hunt LLP | Reiterate | Buy |
| 2021-04-15 | Liberum Capital | Reiterate | Buy |
PURETECH HEALTH PLC - ADR / PRTC FAQ
What do analysts expect the price target to be for PURETECH HEALTH PLC - ADR (PRTC)?
5 analysts have analysed PRTC and the average price target is 67.76 USD. This implies a price increase of 304.56% is expected in the next year compared to the current price of 16.75.
Can you provide the consensus rating for PURETECH HEALTH PLC - ADR stock?
The consensus rating for PURETECH HEALTH PLC - ADR (PRTC) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed PURETECH HEALTH PLC - ADR (PRTC)?
The number of analysts covering PURETECH HEALTH PLC - ADR (PRTC) is 5.